News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
March, 2025
March 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
31  
Alper Topal: The Keynote 921 study failed for CRPC
Alper Topal/researchgate.net
Mar 18, 2025, 12:35

Alper Topal: The Keynote 921 study failed for CRPC

Alper Topal, Medical Onoclogist at Gülhane Training and Research Hospital, shared a paper Daniel P. Petrylak and colleagues authored on X:

“The Keynote 921 study failed for CRPC.

mPFS was 8.6 months in the pembro arm compared to 8.3 months in the placebo arm.mOS was 19.6 months in the pembro arm compared to 19 months in the placebo arm. Grade 3≥side effects were more common in the pembro arm.”

Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial

Authors: Daniel P. Petrylak et al.

Alper Topal

Alper Topal Andrew J. Armstrong Andries M. Bergman cancer Charles Schloss Christian H. Poehlein Daniel P. Petrylak Eric Levesque Ernesto Korbenfeld Gero Kramer Howard Gurney Karim Fizazi Loic Mourey Margitta Retz Maria De Santis Meital Levartovsky Nobuaki Matsubara OncoDaily Oncology Pawel Zalewski Raffaele Ratta Ray Manneh Ray McDermott Russell Pachynski Rustem Gafanov Seok Soo Byun Sergio Bracarda Tilman Todenhofer Winald Gerritsen Xin Tong Li
Special Coverage
Blog
Mar 18, 2025, 17:08
Mazvita Sengayi-Muchengeti: I co-chaired session on HPV-driven cancers at EUROGIN 2025
Positive
Mar 18, 2025, 16:54
The launch of the official JCO Journals LinkedIn page
Blog
Mar 18, 2025, 16:25
Lung Cancer Considered in Cantonese with David D. W. Lee and Molly Li - IASLC
Blog
Mar 18, 2025, 16:15
Digestive cancers under 50 have surged by 80% over the past 30 years - Digestive Cancers Europe
Blog
Mar 18, 2025, 16:07
Giselle Sholler: Honored to receive the Hero’s of Hope Award at The Hope Gala
Blog
Mar 18, 2025, 15:57
William Dale: Left my memento on behalf of the entire Geriatric Oncology community at the Mount Everest Base Camp
Insight
Mar 18, 2025, 15:10
Robert Miller: Using Epic Signal data to show increased EHR workload and message volume in oncology
Blog
Mar 18, 2025, 14:56
Sendurai Mani: A video from my postdoctoral mentor on cancer stem cells and EMT
Science
Mar 18, 2025, 14:49
Yan Leyfman: New study challenges the 8-week driving restriction for patients receiving CAR-T therapy for MM
Blog
Mar 18, 2025, 14:40
Jordan Johnson: Why Bridge Oncology is positioned the way it is
Celebrities
Mar 18, 2025, 13:35
Amy Dowden and Breast Cancer: How She Went Against It, How She Survived, and More
Blog
Mar 18, 2025, 13:16
Magdalena Skipper: Scientists at work photo competition